 Antibodies synthetic peptides Epstein-Barr nuclear sera patients early rheumatoid arthritis preillness sera IgG antibody levels synthetic peptides Epstein-Barr nuclear protein sequence sera patients rheumatoid arthritis RA pre-RA rheumatoid factor RF positive non-RA sera Finland antibody levels RA sera RF negative RF positive nonrheumatoid controls concentrations antibodies preillness sera RA sera Eight-year followup samples patients RA levels antibodies samples months disease onset antibody levels groups Thus levels antibodies glycine peptides clinical RA